Therefore, sPDL2 may promote cancer invasion via interacting with membrane PD-1 on immune cells, and high PDL2 expression in the tumor may also increase the risk of invasive disease in NSCLC patients. The gene discussed is PDCD1LG2; the disease is cancer.